Based on observation, interview and record review, the facility failed to identify medication regimen (a treatment plan that specifies the dosage, the schedule, and the duration of treatment) irregularities in the frequent administration of PRN (as needed) medications for four of 11 sampled residents (Residents 1, 2, 3, and 4) who were prescribed controlled substance medications (drug or other substance that is tightly controlled by the government because it may be abused or cause addiction). 1. Resident 1 received 72 doses of [MEDICATION(S)] (a drug used to treat moderate to severe pain) 5/325 milligrams (mg, unit of measurement) between 7/3/2021 and 8/28/2021. 2. …
F756 citations in California
Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
California cites F756 less often than its own record predicts
0.97 times the national share — cited less often here than elsewhere.
Of every deficiency written in California in 2025, this is the portion that was F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What California surveyors wrote
F756 findings written in California, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on observations, interviews, and record reviews, the facility failed to ensure that the consultant pharmacists (a professional qualified to prepare and dispense medicinal drugs) conducted thorough [MEDICAL CONDITION] (medications or drugs that affect a person's mental state) medication regimen reviews by reviewing the residents' clinical records, and identifying and communicating the medication regimen irregularities to the physician, the facility's medical director and Director of Nursing (DON) for 24 of 24 sampled residents (Residents 5, 10, 11, 14, 16, 17, 18, 19, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 36, and 37.) The consultant pharmacy did not identify that Resident 17 refused doses of [MEDICATION NAME] (ziprasidone, an antipsychotic medication indicated for… …
Based on interview, record review, and facility document review, the Consultant Pharmacist (CP) did not identify Medication Regimen Review (MRR) irregularities for one of five sampled residents (Resident 5) when the resident was receiving a higher-than-recommended dose of apixaban (a blood thinning medication) despite meeting criteria requiring a reduced dose.This resulted in potential adverse effects, including excessive bleeding for Resident 5.Findings:Resident 5 was an [AGE] year-old dependent on dialysis with limited kidney function admitted to the facility from an acute care hospital.A review of apixaban's Prescribing Information (PI), dated 4/25, the PI indicated, In patients with at least 2 of the following characteristics: age greater than or equal to 80 years.serum creatinine… …
The short window
Recent years
| Year | Share of California citations | vs expected |
|---|---|---|
| 2023 | 0.79% | 0.84× |
| 2024 | 0.80% | 0.98× |
| 2025 | 0.77% | 0.97× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else California surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction